Your session is about to expire
← Back to Search
Behavioural Intervention
Combined Osteopathic and Exercise Therapy for Cervicogenic Headache (CGH Trial)
Phase 1 & 2
Recruiting
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Females diagnosed with chronic cervicogenic headache.
Be older than 18 years old
Must not have
Ongoing central nervous system pathology such as hemiparesis, cervical radiculopathy, spondylolisthesis grade III or IV, central nervous system causes of balance & coordination deficits, orthostatic hypotension, vestibular disorders, pregnancy, recent spinal fractures, moderate to severe traumatic brain injury.
History of spinal surgery performed on the neck
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a combination of hands-on therapy and specific exercises to treat chronic headaches caused by neck problems. It focuses on women aged 18 to 75 who suffer from these headaches. The treatment aims to improve neck muscle health, which is expected to reduce headache pain, frequency, and duration.
Who is the study for?
This trial is for women aged 18-75 with chronic cervicogenic headache, which is a type of headache originating from the neck. Participants should not have been in a rear-end car accident within the last 3 years, had neck surgery, or suffer from certain diseases like rheumatoid arthritis or lupus.
What is being tested?
The study tests if Osteopathic Manipulative Therapy (OMT) combined with targeted head exercises can reduce headache frequency, intensity, and duration compared to standard medical care alone. It's a randomized controlled trial focusing on muscle pathology related to headaches.
What are the potential side effects?
While specific side effects are not listed here, OMT and exercise therapy may typically include soreness or discomfort in treated areas. Any unexpected side effects will be monitored throughout the trial.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman diagnosed with chronic headaches originating from the neck.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have severe brain or spinal issues, balance problems, or am not pregnant.
Select...
I have had surgery on my neck.
Select...
I have been diagnosed with rheumatoid arthritis, lupus, or ankylosing spondylitis.
Select...
I have a pinched nerve in my neck causing arm pain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cervicogenic Headache
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
All subjects in the Treatment group will receive OMT a minimum 4 times and a maximum of 8 times at the physician's (JJR) discretion (Jull et al., 2002). All subjects in the Treatment group will be taught the THE. This voluntary head retraction/protrusion exercise protocol engages the RCPm muscles in eccentric and isometric contractions that should strengthen the muscles and thereby increase CSA.
Group II: ControlActive Control1 Intervention
All subjects assigned to the Control group will be allowed to continue to receive conservative care. It is understood that any care that they receive will be prescribed on an individual basis. A participant could therefore receive any combination of medical, physio therapeutic and psychological care. It would also be expected that some form of pain management will be a priority for participants with moderate to severe symptoms. Subjects assigned to the Control group will not receive OMT and will not be taught the THE protocol.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Osteopathic Manipulative Treatment (OMT) and Targeted Head Exercise (THE) are common treatments for Cervicogenic Headache (CeH) that focus on improving musculoskeletal function and reducing referred headache pain. OMT uses manual techniques to correct dysfunctions in the cervical spine and surrounding tissues, while THE involves specific exercises to strengthen and restore normal function to the rectus capitis posterior minor (RCPm) muscles.
These treatments are important for CeH patients as they address muscle pathology and improve muscle function, thereby targeting the underlying causes of their headache symptoms.
Find a Location
Who is running the clinical trial?
Michigan State UniversityLead Sponsor
198 Previous Clinical Trials
685,725 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have severe brain or spinal issues, balance problems, or am not pregnant.I have had surgery on my neck.You were in a car accident where another car hit you from behind in the last 3 years.I have been diagnosed with rheumatoid arthritis, lupus, or ankylosing spondylitis.I am a woman diagnosed with chronic headaches originating from the neck.I have a pinched nerve in my neck causing arm pain.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.